Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma

NCT00006250 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: chlorambucil
DRUG: dexamethasone
DRUG: fludarabine phosphate
DRUG: mitoxantrone hydrochloride

Sponsor

Lymphoma Trials Office